摘要
目的观察多索茶碱治疗肺癌术后并发支气管哮喘的临床疗效。方法87例肺癌术后并发支气管哮喘患者分为多索茶碱治疗组(A组)和氨茶碱对照组(B组),观察和对比两组患者治疗后的临床症状、血气变化及不良反应发生率。结果A组患者临床总有效率高于B组,且心悸、恶心、失眠等不良反应发生率低于B组,两组比较差异有显著性意义(P<0.05)。结论多索茶碱治疗肺癌术后并发支气管哮喘安全、有效。
Objective To investigate and evaluate the clinical results of doxofylline for bronchail asthma following lung cancer surgery.Methods 87 cases of bronchial asthma patients following lung cancer surgery were randomly divided into doxofylline treatment group（Group A） and aminophylline treatment group（Group B）.Clinical symptoms,blood gas index and the incidence rate of adverse reaction were observed and compared.Results The cough,gasp and lung wheezing rale of Group A patients were obviously remitted,and partial pressure of oxygen and partial pressure of carbon dioxide were evidently improved.The total clinical effective rate of Group A was higher than that of Group B,and the incidence rate of adverse reaction such as palpitation,nausea and agrypnia was lower.The disparity between two groups was significant（P 〈 0.05）.Conclusions Doxofylline was a safe and effective drug for the treatment to bronchail asthma following lung cancer surgery.
出处
《实用医院临床杂志》
2009年第3期83-84,共2页
Practical Journal of Clinical Medicine
关键词
多索茶碱
肺癌
手术
支气管哮喘
并发症
Doxofylline
Long cancer
Surgery
Bronchial asthma
Complication
